Sachin Badrinath Surade

Title: Sachin Badrinath Surade: Innovator in Antibody Molecules and Sodium Channel Inhibitors

Introduction

Sachin Badrinath Surade is a notable inventor based in Sawston, GB. He has made significant contributions to the field of biotechnology, particularly in the development of antibody molecules and sodium channel inhibitors. With a total of 2 patents, his work has the potential to impact medical treatments significantly.

Latest Patents

Surade's latest patents include innovative antibody molecules that specifically bind to PD-L1. This disclosure provides methods for creating and utilizing these antibody molecules, which may have applications in cancer therapy. Additionally, he has developed sodium channel inhibitors that target the Nav1.7 channel, which are useful in treating pain and epilepsy. These binding members consist of a fusion protein that enhances specificity for Nav1.7 over other sodium channels, showcasing his expertise in molecular design.

Career Highlights

Throughout his career, Surade has worked with prominent companies such as Invox Pharma Limited and Maxion Therapeutics Limited. His experience in these organizations has allowed him to collaborate on groundbreaking research and development projects, further establishing his reputation in the industry.

Collaborations

Surade has collaborated with notable colleagues, including Francisca Wollerton and Matthew Lakins. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Sachin Badrinath Surade is a distinguished inventor whose work in antibody molecules and sodium channel inhibitors holds promise for future medical advancements. His contributions to biotechnology continue to pave the way for innovative treatments.